A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
Clinical trial NCT06106828 · COMPLETED
Trial details
- NCT number
- NCT06106828
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-15
- Primary completion
- 2025-07-24
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.